Evaluation of the clinical utility of measuring serum infliximab and vedolizumab concentrations during monitoring of biologic therapy in patients with inflammatory bowel disease
{{output}}
Introduction: Infliximab (IFX) and vedolizumab (VDZ) are monoclonal antibodies used for the treatment of inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC). The concentration of biologic ... ...
